TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 44 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,667 | +62.9% | 6,540 | -65.9% | 0.00% | – |
| Q2 2023 | $12,686 | +293.2% | 19,193 | +374.5% | 0.00% | – |
| Q1 2023 | $3,226 | +12.6% | 4,045 | +219.0% | 0.00% | – |
| Q4 2022 | $2,866 | +43.3% | 1,268 | +33.5% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 950 | +482.8% | 0.00% | – |
| Q2 2022 | $1,000 | -88.9% | 163 | -88.7% | 0.00% | – |
| Q1 2022 | $9,000 | -91.8% | 1,445 | -84.7% | 0.00% | – |
| Q4 2021 | $110,000 | -90.6% | 9,459 | -83.5% | 0.00% | – |
| Q1 2021 | $1,166,000 | +253.3% | 57,412 | +361.5% | 0.00% | – |
| Q4 2020 | $330,000 | – | 12,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |